Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 421

1.

Non-Enzymatic Glycation and Degree of Mineralization Are Higher in Bone from Fractured Patients With Type 1 Diabetes Mellitus.

Farlay D, Armas L, Gineyts E, Akhter M, Recker R, Boivin G.

J Bone Miner Res. 2015 Aug 1. doi: 10.1002/jbmr.2607. [Epub ahead of print]

PMID:
26234180
2.

Marrow adiposity assessed on transiliac crest biopsy samples correlates with noninvasive measurement of marrow adiposity by proton magnetic resonance spectroscopy (1H-MRS) at the spine but not the femur.

Cohen A, Shen W, Dempster DW, Zhou H, Recker RR, Lappe JM, Kepley A, Kamanda-Kosseh M, Bucovsky M, Stein EM, Nickolas TL, Shane E.

Osteoporos Int. 2015 May 19. [Epub ahead of print]

PMID:
25986383
3.

Self-reported calcium use in a cohort of postmenopausal women receiving osteoporosis therapy: results from POSSIBLE US™.

Barrett-Connor E, Wade SW, Downs RW, Ganiats T, Hochberg M, Recker RR, Stolshek BS.

Osteoporos Int. 2015 Aug;26(8):2175-84. doi: 10.1007/s00198-015-3128-8. Epub 2015 Apr 16.

PMID:
25876880
4.

The Effect of Discontinuing Treatment With Blosozumab: Follow-up Results of a Phase 2 Randomized Clinical Trial in Postmenopausal Women With Low Bone Mineral Density.

Recknor CP, Recker RR, Benson CT, Robins DA, Chiang AY, Alam J, Hu L, Matsumoto T, Sowa H, Sloan JH, Konrad RJ, Mitlak BH, Sipos AA.

J Bone Miner Res. 2015 Feb 24. doi: 10.1002/jbmr.2489. [Epub ahead of print]

PMID:
25707611
5.

Comprehensive analysis of the association of EGFR, CALM3 and SMARCD1 gene polymorphisms with BMD in Caucasian women.

Zhou QH, Zhao LJ, Wang P, Badr R, Xu XJ, Bu FX, Lappe J, Recker R, Zhou Y, Ye A, Zhou BT.

PLoS One. 2014 Nov 14;9(11):e112358. doi: 10.1371/journal.pone.0112358. eCollection 2014.

6.

Bone safety with risedronate: histomorphometric studies at different dose levels and exposure.

Recker RR, Ste-Marie LG, Chavassieux P, McClung MR, Lundy MW.

Osteoporos Int. 2015 Jan;26(1):327-37. doi: 10.1007/s00198-014-2850-y. Epub 2014 Oct 11.

PMID:
25304456
7.

A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density.

Recker RR, Benson CT, Matsumoto T, Bolognese MA, Robins DA, Alam J, Chiang AY, Hu L, Krege JH, Sowa H, Mitlak BH, Myers SL.

J Bone Miner Res. 2015 Feb;30(2):216-24. doi: 10.1002/jbmr.2351.

8.

Relationship of bone mineralization density distribution (BMDD) in cortical and cancellous bone within the iliac crest of healthy premenopausal women.

Misof BM, Dempster DW, Zhou H, Roschger P, Fratzl-Zelman N, Fratzl P, Silverberg SJ, Shane E, Cohen A, Stein E, Nickolas TL, Recker RR, Lappe J, Bilezikian JP, Klaushofer K.

Calcif Tissue Int. 2014 Oct;95(4):332-9. doi: 10.1007/s00223-014-9901-4. Epub 2014 Aug 19.

PMID:
25134800
9.

MiR-422a as a potential cellular microRNA biomarker for postmenopausal osteoporosis.

Cao Z, Moore BT, Wang Y, Peng XH, Lappe JM, Recker RR, Xiao P.

PLoS One. 2014 May 12;9(5):e97098. doi: 10.1371/journal.pone.0097098. eCollection 2014.

10.

Teriparatide increases strength of the peripheral skeleton in premenopausal women with idiopathic osteoporosis: a pilot HR-pQCT study.

Nishiyama KK, Cohen A, Young P, Wang J, Lappe JM, Guo XE, Dempster DW, Recker RR, Shane E.

J Clin Endocrinol Metab. 2014 Jul;99(7):2418-25. doi: 10.1210/jc.2014-1041. Epub 2014 Mar 31.

11.

Long-term fracture rates seen with continued ibandronate treatment: pooled analysis of DIVA and MOBILE long-term extension studies.

Miller PD, Recker RR, Harris S, Silverman S, Felsenberg D, Reginster J, Day BM, Barr C, Masanauskaite D.

Osteoporos Int. 2014 Jan;25(1):349-57. doi: 10.1007/s00198-013-2518-z. Epub 2013 Oct 18.

PMID:
24136103
12.

DNA methylation levels of CYP2R1 and CYP24A1 predict vitamin D response variation.

Zhou Y, Zhao LJ, Xu X, Ye A, Travers-Gustafson D, Zhou B, Wang HW, Zhang W, Lee Hamm L, Deng HW, Recker RR, Lappe JM.

J Steroid Biochem Mol Biol. 2014 Oct;144 Pt A:207-14. doi: 10.1016/j.jsbmb.2013.10.004. Epub 2013 Oct 12. Review.

PMID:
24128439
13.

Successful treatment of tumor-induced osteomalacia due to an intracranial tumor by fractionated stereotactic radiotherapy.

Tarasova VD, Trepp-Carrasco AG, Thompson R, Recker RR, Chong WH, Collins MT, Armas LA.

J Clin Endocrinol Metab. 2013 Nov;98(11):4267-72. doi: 10.1210/jc.2013-2528. Epub 2013 Sep 6.

PMID:
24014621
14.

Transmenopausal changes in trabecular bone quality.

Gamsjaeger S, Brozek W, Recker R, Klaushofer K, Paschalis EP.

J Bone Miner Res. 2014 Mar;29(3):608-17. doi: 10.1002/jbmr.2073.

PMID:
23966337
15.

Inhibition of transketolase by oxythiamine altered dynamics of protein signals in pancreatic cancer cells.

Wang J, Zhang X, Ma D, Lee WN, Xiao J, Zhao Y, Go VL, Wang Q, Yen Y, Recker R, Xiao GG.

Exp Hematol Oncol. 2013 Jul 27;2:18. doi: 10.1186/2162-3619-2-18. eCollection 2013.

16.

Excessive aluminum accumulation in the bones of patients on long-term parenteral nutrition: postmortem analysis by electrothermal atomic absorption spectrometry.

Kruger PC, Parsons PJ, Galusha AL, Morrissette M, Recker RR, Howard LJ.

JPEN J Parenter Enteral Nutr. 2014 Aug;38(6):728-35. doi: 10.1177/0148607113491981. Epub 2013 Jun 13.

PMID:
23765064
17.

Teriparatide for idiopathic osteoporosis in premenopausal women: a pilot study.

Cohen A, Stein EM, Recker RR, Lappe JM, Dempster DW, Zhou H, Cremers S, McMahon DJ, Nickolas TL, Müller R, Zwahlen A, Young P, Stubby J, Shane E.

J Clin Endocrinol Metab. 2013 May;98(5):1971-81. doi: 10.1210/jc.2013-1172. Epub 2013 Mar 29.

18.

Abdominal fat is associated with lower bone formation and inferior bone quality in healthy premenopausal women: a transiliac bone biopsy study.

Cohen A, Dempster DW, Recker RR, Lappe JM, Zhou H, Zwahlen A, Müller R, Zhao B, Guo X, Lang T, Saeed I, Liu XS, Guo XE, Cremers S, Rosen CJ, Stein EM, Nickolas TL, McMahon DJ, Young P, Shane E.

J Clin Endocrinol Metab. 2013 Jun;98(6):2562-72. doi: 10.1210/jc.2013-1047. Epub 2013 Mar 20.

19.

Bone density, turnover, and estimated strength in postmenopausal women treated with odanacatib: a randomized trial.

Brixen K, Chapurlat R, Cheung AM, Keaveny TM, Fuerst T, Engelke K, Recker R, Dardzinski B, Verbruggen N, Ather S, Rosenberg E, de Papp AE.

J Clin Endocrinol Metab. 2013 Feb;98(2):571-80. doi: 10.1210/jc.2012-2972. Epub 2013 Jan 21.

PMID:
23337728
20.

Effects of 3 years treatment with once-yearly zoledronic acid on the kinetics of bone matrix maturation in osteoporotic patients.

Gamsjaeger S, Hofstetter B, Zwettler E, Recker R, Gasser JA, Eriksen EF, Klaushofer K, Paschalis EP.

Osteoporos Int. 2013 Jan;24(1):339-47. doi: 10.1007/s00198-012-2202-8. Epub 2012 Nov 15.

PMID:
23229465
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk